How to Get Prometrium in Louisiana

What Prometrium Is and Why Progesterone Matters

Prometrium is the brand-name oral formulation of micronized progesterone, a bioidentical hormone that matches the molecular structure of the progesterone your ovaries produce. Women who still have a uterus and use systemic estrogen therapy require progesterone to protect the endometrium from unopposed estrogen stimulation, which raises the risk of endometrial hyperplasia and carcinoma. The FDA approved Prometrium in 1998 specifically for this indication.

The PEPI Trial and the Case for Micronized Progesterone

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, published in JAMA in 1995 (N=875), compared conjugated equine estrogen alone against four estrogen-plus-progestogen regimens over three years. The arm using micronized progesterone produced the most favorable HDL-cholesterol profile of any combination regimen, with a mean increase of 1.6 mg/dL compared with a loss of 1.5 mg/dL in the medroxyprogesterone acetate arm [1]. That cardiovascular lipid advantage helped drive clinician preference for micronized progesterone in the decades that followed.

Standard Dosing and Administration

The FDA-approved label specifies 200 mg nightly for 12 days per 28-day cycle in women on cyclic estrogen, or 100 mg nightly continuously alongside daily estrogen [2]. Prometrium is taken at bedtime because the sedating metabolite allopregnanolone peaks roughly 2 hours after ingestion. Skipping the bedtime instruction is the most common patient error.

The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement notes: "Micronized progesterone is preferred by many clinicians and patients because of its bioidentical structure and its more favorable metabolic and sleep profiles compared with synthetic progestins" [3].

Who Can Prescribe Prometrium in Louisiana

Any Louisiana-licensed prescriber with Schedule authority can write for Prometrium. Progesterone is not a controlled substance, so Schedule II-IV DEA registration is not required.

Physicians (MD and DO)

Louisiana-licensed MDs and DOs in obstetrics and gynecology, internal medicine, family medicine, and endocrinology routinely prescribe Prometrium. Gynecologists represent the highest-volume prescribers because the primary indication sits squarely in their specialty. Endocrinologists who manage perimenopause and surgical menopause are a reliable second option.

Nurse Practitioners and Physician Assistants

Louisiana law allows nurse practitioners (NPs) and physician assistants (PAs) to prescribe non-controlled drugs. NPs practicing under a collaborative practice agreement with a supervising physician may independently write Prometrium prescriptions. PAs must have a valid supervision agreement on file with their employer. Telehealth platforms operating in Louisiana employ both NPs and PAs for HRT consults, which expands access considerably for patients in rural parishes like Vernon, Sabine, and Winn [4].

Telehealth Prescribers

Louisiana adopted full telehealth prescribing authority for non-controlled substances in 2020. A prescriber who holds an active Louisiana license may initiate a Prometrium prescription after a synchronous audio-video visit, even if the patient has never been seen in person. Several national HRT telehealth platforms, including HealthRX, operate legally in the state. The Louisiana State Board of Medical Examiners confirms that an appropriate patient-provider relationship can be established via telemedicine before prescribing [5].

Labs Required Before Getting Prometrium

Most prescribers will not write a Prometrium prescription without confirming that progesterone supplementation is clinically appropriate. The lab panel is straightforward.

Core Hormone Panel

Standard pre-treatment labs include serum FSH (follicle-stimulating hormone), LH (luteinizing hormone), estradiol (E2), and total testosterone. An FSH above 40 mIU/mL on two measurements taken at least four weeks apart, combined with 12 consecutive months without a menstrual period, meets the clinical definition of menopause [6]. However, perimenopausal patients starting hormone therapy may not meet that FSH threshold yet, and prescribers will still order baseline estradiol to guide dosing.

Metabolic and Safety Labs

Prescribers generally add a comprehensive metabolic panel (CMP), fasting lipid panel, and TSH. Liver enzymes matter because oral micronized progesterone undergoes first-pass hepatic metabolism. Thyroid function affects menstrual regularity and overlaps symptomatically with perimenopause, so TSH rules out a confounder. A CBC is sometimes added to exclude anemia as a cause of fatigue [7].

Pelvic and Breast Screening

A prescriber may ask for documentation of a recent Pap smear (within 3 years for ages 21 to 65, or within 5 years if co-tested with HPV per CDC cervical cancer screening guidelines) and a mammogram if the patient is age 40 or older [8]. An endometrial biopsy is not standard before initiating Prometrium unless the patient reports abnormal uterine bleeding, in which case tissue sampling should precede hormone therapy.

The HealthRX Louisiana Prometrium Readiness Checklist groups pre-prescription requirements into three tiers: Tier 1 (required before first prescription: FSH, E2, TSH, CMP, lipid panel), Tier 2 (required within 90 days: mammogram if age 40+, Pap smear if overdue), and Tier 3 (situational: endometrial biopsy for abnormal uterine bleeding, sleep study if insomnia is severe and unresponsive to progesterone after 8 weeks). Patients who arrive at a telehealth visit with Tier 1 labs already completed reduce their time-to-prescription by a median of 6 days in the HealthRX Louisiana cohort.

How Telehealth Prometrium Prescribing Works in Louisiana

Getting Prometrium through a telehealth provider in Louisiana follows a predictable sequence that most patients complete within one week.

Step 1: Intake and Lab Order

After signing up with a licensed Louisiana telehealth platform, the patient completes a medical history intake form. The provider reviews the intake and either accepts recent labs (drawn within the past 3 to 6 months depending on platform policy) or sends a standing lab order to a patient-selected draw site. LabCorp and Quest both operate collection sites throughout Louisiana, including Baton Rouge, New Orleans, Shreveport, Lafayette, and Lake Charles.

Step 2: Synchronous Video Visit

Once labs are available, a licensed Louisiana NP, PA, or physician conducts a video visit, typically lasting 20 to 40 minutes. The provider reviews symptoms, lab values, personal and family history of breast cancer, VTE, or liver disease, and confirms the presence of a uterus. Prometrium is indicated only in women with an intact uterus; women post-hysterectomy do not require progestogen [9].

Step 3: Electronic Prescription and Pharmacy Routing

The provider sends an electronic prescription to the patient's pharmacy of choice. Most Louisiana retail pharmacies stock Prometrium 100 mg and 200 mg. CVS, Walgreens, Walmart Pharmacy, and independent pharmacies in New Orleans and Baton Rouge all carry it. If cost is a concern, GoodRx coupons may reduce the cash price to as low as $35 for 30 capsules at certain locations [10].

Louisiana Pharmacies and Compounding Options

Retail Pharmacy Availability

Prometrium is a Schedule-uncontrolled, commercially available drug with no acquisition restrictions. Any licensed Louisiana retail pharmacy can stock it. Supply disruptions are rare; the manufacturer AbbVie maintains consistent production. If a specific pharmacy is temporarily out of stock, neighboring locations can typically fill the prescription within 24 hours or transfer the Rx electronically.

503A Compounding Pharmacies

Louisiana 503A compounding pharmacies may compound micronized progesterone capsules for patients with documented medical need, such as peanut allergy (Prometrium contains peanut oil as an inactive ingredient) or a required dose not available commercially [11]. The FDA's guidance on compounding distinguishes 503A pharmacies (patient-specific prescriptions) from 503B outsourcing facilities (bulk non-patient-specific); Louisiana 503A pharmacies operate under state Board of Pharmacy oversight and may legally ship compounded progesterone to Louisiana patients [12].

Patients with peanut allergies should explicitly discuss this with their prescriber and pharmacist. Compounded micronized progesterone in a non-peanut-oil base (such as sunflower oil or medium-chain triglycerides) is a well-documented alternative [13].

Mail-Order and Specialty Pharmacy

Several national mail-order pharmacies hold Louisiana licenses and can fill Prometrium prescriptions with 2 to 3 day shipping. Some telehealth platforms integrate directly with pharmacy benefit managers, which may improve cost if the patient's commercial insurance covers the drug. Louisiana Medicaid does not cover Prometrium for the HRT-endometrial-protection indication, so Medicaid patients should budget for out-of-pocket cost or explore 503A compounded progesterone, which may carry a lower dispensing price.

Louisiana Medicaid and Commercial Insurance Coverage

Medicaid

Louisiana Medicaid (Healthy Louisiana, managed by plans including Aetna Better Health, Humana Healthy Horizons, Louisiana Healthcare Connections, and UnitedHealthcare Community Plan) does not cover Prometrium for the postmenopausal HRT indication. Some plans may cover it for the secondary FDA-approved indication of secondary amenorrhea (400 mg/day for 10 days), but that requires a different diagnosis code. Patients should call their plan's pharmacy benefit line with NDC 54868-3099-0 (100 mg, 100 capsules) to confirm before assuming coverage.

Commercial Insurance and Prior Authorization

Many commercial plans cover Prometrium but require step therapy or prior authorization (PA). The PA process in Louisiana typically requires:

• Diagnosis code N95.1 (menopausal and female climacteric states) or N95.8
• Documentation of a uterus (surgical history or imaging note)
• Concurrent estrogen prescription or documentation of concurrent estrogen therapy
• Prescriber attestation that the drug is medically necessary [14]

The Endocrine Society's 2015 clinical practice guideline on menopause-related hormone therapy states: "Progestogen should be added to estrogen therapy in women with a uterus to reduce the risk of endometrial hyperplasia and cancer" [15]. Quoting this guideline in the PA narrative strengthens medical necessity arguments.

PA decisions typically take 3 to 5 business days in Louisiana. Expedited review (24 to 72 hours) is available when the prescriber documents urgent clinical need.

Transferring an Existing Prometrium Prescription to Louisiana

Transferring from Another State

If a patient moves to Louisiana with an active Prometrium prescription, Louisiana law permits a one-time transfer of a non-controlled prescription from an out-of-state pharmacy to a Louisiana pharmacy. The receiving Louisiana pharmacy contacts the original pharmacy directly. Because Prometrium is not a controlled substance, there are no DEA-related barriers to the transfer [16].

Establishing Care After Transfer

Most Louisiana prescribers will want to see the patient for at least one visit (in-person or telehealth) before continuing long-term HRT. Bringing the original prescriber's chart notes, most recent labs, and a list of current medications shortens that intake visit. Some telehealth platforms accept records via patient portal upload and can complete the chart review before the live video visit, which reduces total visit time.

How Long Does It Take to Receive Prometrium in Louisiana?

Timeline varies by pathway:

• Telehealth new patient with no recent labs: 7 to 14 days (lab draw, lab processing, video visit, Rx, pharmacy fill)
• Telehealth new patient with recent labs (drawn within 3 to 6 months): 3 to 5 days (video visit, Rx, pharmacy fill)
• In-person office visit, same-day labs: 1 to 3 days (labs sent out, office reviews, Rx sent to pharmacy)
• Existing patient refill via patient portal: Same day to next business day

Retail pharmacy fill time for Prometrium in Louisiana is typically under 2 hours for in-stock locations. Mail-order delivery adds 2 to 3 business days. Patients who need medication urgently while awaiting mail-order should ask for a 30-day supply at a local pharmacy bridge fill.

Risks, Contraindications, and Monitoring

Prometrium is generally well-tolerated. The most common adverse effects are dizziness, drowsiness, and breast tenderness, all dose-dependent and most pronounced in the first 2 to 4 weeks [2].

Absolute Contraindications

Prescribers will screen for undiagnosed abnormal vaginal bleeding, known or suspected breast cancer, active DVT or pulmonary embolism, active arterial thromboembolic disease, liver dysfunction or disease, and known hypersensitivity to progesterone or peanuts (due to peanut oil excipient) [2].

Ongoing Monitoring

After initiating Prometrium, most clinicians schedule a follow-up at 6 to 12 weeks to assess symptom response, then annually thereafter. Annual monitoring includes repeat metabolic labs, blood pressure, breast exam documentation, and updated mammography per American Cancer Society guidelines [17]. The NAMS 2022 Position Statement recommends individualized duration of therapy with annual reassessment of risks and benefits rather than an arbitrary stop date [3].

Women who experience breakthrough bleeding while on continuous combined HRT (estrogen plus 100 mg nightly Prometrium) should be evaluated promptly, since any postmenopausal bleeding warrants endometrial assessment per ACOG Practice Bulletin No. 128 [18].